Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

HPTN 083 interim analysis shows LA cabotegravir highly effective at preventing HIV

May 18, 2020

ViiV Healthcare discovers new HIV-1 Capsid protein p24 assembly inhibitors

May 14, 2020

Chinese researchers identify new TLR7 agonists

May 8, 2020

Cabo as next annual shot?

May 8, 2020

Viriom initiates phase II study of long-acting injectable VM-1500A

May 5, 2020

ViiV Healthcare presents compounds for HIV infection

April 6, 2020

ViiV Healthcare presents new HIV replication inhibitors

April 1, 2020

Antibody gene therapy with AAV8-VRC07 appears feasible in HIV patients

March 24, 2020

Health Canada grants first global regulatory approval for Cabenuva

March 23, 2020

Expression of broadly neutralizing anti-HIV Abs by aerosol delivery of synthetic mRNA to the vagina

March 20, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...